Plasmodium vivax Relapse Rates Following Plasmodium falciparum Malaria Reflect Previous Transmission Intensity.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
05 06 2019
Historique:
received: 16 01 2019
accepted: 28 01 2019
pubmed: 31 1 2019
medline: 25 2 2020
entrez: 31 1 2019
Statut: ppublish

Résumé

From 2003 through 2009, 687 of 2885 patients (23.8%) treated for Plasmodium falciparum malaria in clinical studies in Myanmar or on the Thailand-Myanmar border had recurrent Plasmodium vivax malaria within 63 days, compared with 18 of 429 patients (4.2%) from 2010 onward (risk ratio [RR], 0.176; 95% confidence interval, .112-.278; P < .0001). Corresponding data from 42 days of follow-up revealed that 820 of 3883 patients (21.1%) had recurrent P. vivax malaria before 2010, compared with 22 of 886 (2.5%) from 2010 onward (RR, 0.117; 95% CI, .077-.177; P < .0001). This 6-fold reduction suggests a recent decline in P. vivax transmission intensity and, thus, a substantial reduction in the proportion of individuals harboring hypnozoites.

Identifiants

pubmed: 30698794
pii: 5304105
doi: 10.1093/infdis/jiz052
pmc: PMC6548896
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100-104

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.

Références

Lancet. 1987 Nov 7;2(8567):1052-5
pubmed: 2889965
Trans R Soc Trop Med Hyg. 1997 Jul-Aug;91(4):468-72
pubmed: 9373658
Lancet Infect Dis. 2019 Jan;19(1):10-12
pubmed: 30587279
Clin Infect Dis. 2011 Mar 1;52(5):612-20
pubmed: 21292666
Lancet Infect Dis. 2019 Jan;19(1):91-101
pubmed: 30587297
Bull World Health Organ. 1977;55(5):541-9
pubmed: 338188
Lancet Infect Dis. 2010 Oct;10(10):673-81
pubmed: 20832366
J Infect Dis. 2012 Feb 15;205(4):680-3
pubmed: 22194628
Malar J. 2011 Aug 31;10:253
pubmed: 21880138
PLoS Med. 2013;10(3):e1001398
pubmed: 23472056
Malar J. 2011 Oct 11;10:297
pubmed: 21989376

Auteurs

Elizabeth A Ashley (EA)

Myanmar Oxford Clinical Research Unit, Myanmar.
Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, United Kingdom.

Aung Pyae Phyo (AP)

Myanmar Oxford Clinical Research Unit, Myanmar.
Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot.

Verena I Carrara (VI)

Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot.

Kyaw Myo Tun (KM)

Department of Preventive and Social Medicine, Defence Services Medical Academy.

Francois Nosten (F)

Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, United Kingdom.
Shoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot.

Frank Smithuis (F)

Myanmar Oxford Clinical Research Unit, Myanmar.
Medical Action Myanmar, Yangon, Myanmar.
Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, United Kingdom.

Nicholas J White (NJ)

Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, United Kingdom.
Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH